Skip to content

Demonstration project of the absorbable collagen membrane

Observational study on the Efficacy of Baigujian® absorbable collagen membrane

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400093060
Enrollment
Unknown
Registered
2024-11-27
Start date
2024-08-22
Completion date
Unknown
Last updated
2024-12-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

alveolar bone defect

Interventions

Case series:none

Sponsors

Xinhua Hospital Affiliated to Shanghai Jiaotong University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) Adults,18<= Age <=80 years,gender is not limited; (2) Patients who need bone grafting; (3) Subjects who agree to participate in this trial and sign the informed consent.

Exclusion criteria

Exclusion criteria: (1) Patients with poor blood glucose and blood pressure control (fasting blood glucose value >8mmol/L, systolic blood pressure >=160mmHg and/or diastolic blood pressure >=100mmHg), uncontrolled systemic infections, serious blood system diseases and other uncontrolled systemic disease who is not suitable for surgery. (2) Currently taking or long-term use of steroids,immunosuppressants or bisphosphonates. (3) Patients who have a history of, or are currently undergoing, radiotherapy or chemotherapy to the head and neck within the last 3 years. (4) Concomitant systemic diseases, such as bone diseases, may cause difficulties in postoperative healing or osseous union. (5) Patients with periapical periodontitis or radicular cyst near the operative region. (6) Women who were known to be pregnant or lactating or who planned to have children during the study period. (7) Patients deemed unsuitable to participate in this clinical trial. (8) Hepatitis B infection period patients. (9) Patients who allergies to biofilm materials.

Design outcomes

Primary

MeasureTime frame
changes in alveolar height and width;

Secondary

MeasureTime frame
wound healing Assessment ;Instrument performance;cost;

Countries

China

Contacts

Public ContactTang Zisheng

Xinhua Hospital Affiliated to Shanghai Jiaotong University School of Medicine

tangzisheng163@163.com+86 133 9106 0531

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026